Lymphoma
BGB-11417-302
Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma.
Trial overview
Clinical Area
Haematology
Disease
Lymphoma
Disease site
Malignant Haematology
Study Phase
III
Trial Identifiers
Registration number: NCT06742996
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries